Working together, Capgemini and Terumo BCT will use the I&D centres to help build next-generation platforms for Terumo BCT’s devices
Capgemini announced that it has been selected by Terumo BCT, a US-based global leader in blood component, therapeutic apheresis and cellular technologies, to set up two global innovation and development (I&D) centres in India. Working together, Capgemini and Terumo BCT will use the I&D centres to help build next-generation platforms for Terumo BCT’s devices.
Capgemini will deliver a multi-disciplinary engagement across research and development, product engineering, and usability engineering. “As technology helps us unlock the potential of blood and cellular therapies, it makes perfect sense for us to collaborate with Capgemini. Their global expertise and best practices from other industries will help us bring about the next-generation of connected medical devices,” said Palani Palaniappan, Executive Vice President, Innovation and Development, Terumo BCT.
Sanjay Salunkhe, Global Head of Product and Engineering Services, Capgemini said, “We are pleased to have been selected by Terumo BCT to help develop innovations that could become industry standards, improve clinical outcomes and lower the costs for their customers.”